Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchExact Sciences Corp. showcases Oncodetect MRD test's capabilities in detecting residual disease at ASCO GI 2025.
Jan 21, 2025
MadisonInformation TechnologyBiotechnologyHealth CareScience And EngineeringHealth Diagnostics
Product Description
Exact Sciences Corp. presented clinical validation data for its Oncodetect MRD test at the ASCO GI 2025 symposium, showing promising sensitivity and specificity results for colorectal cancer patients. The company aims to enhance access to high-quality MRD testing solutions.
Company Information
Company
Exact Sciences
Location
Madison, Wisconsin, United States
About
Exact Sciences Corp. is a leading provider of cancer screening and diagnostic tests, known for its innovative solutions in early cancer detection. The company emphasizes patient-centric approaches and continuous improvement in its offerings, including the Cologuard Plus test for colorectal cancer screening. Exact Sciences collaborates with institutions like the Mayo Clinic to develop advanced diagnostics. Their commitment is to improve adherence and accessibility in cancer screening, particularly in underserved populations.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exact Sciences ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.